Company: TYRA
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0000950170-25-108899
Chunk: 1

Company: Tyra Biosciences, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Item 1
Chunk 1
---
 at June 30, 2025 and    December 31, 2024, respectively, and 53,233,494 and    50,749,945 shares outstanding at June 30, 2025 and    December 31, 2024, respectively.

     5

     5

     Additional paid-in capital

     609,262

     593,687

     Accumulated other comprehensive income

     436

     770

     Accumulated deficit

     (307,556
     )

     (251,311
     )

     Total stockholders’ equity

     302,147

     343,151

     Total liabilities and stockholders’ equity
      
     $
     321,499

     $
     363,558

See accompanying notes to unaudited condensed financial statements.